Yoseph Bornstein Sells 50,000 Shares of Microbot Medical Inc. (MBOT) Stock

Microbot Medical Inc. (NASDAQ:MBOT) Director Yoseph Bornstein sold 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 10th. The shares were sold at an average price of $1.38, for a total value of $69,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Yoseph Bornstein also recently made the following trade(s):

  • On Thursday, October 5th, Yoseph Bornstein sold 22,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.49, for a total value of $32,780.00.
  • On Wednesday, October 4th, Yoseph Bornstein sold 53,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.20, for a total value of $63,600.00.
  • On Tuesday, September 26th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.24, for a total value of $62,000.00.
  • On Tuesday, September 19th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.18, for a total value of $59,000.00.
  • On Tuesday, September 12th, Yoseph Bornstein sold 20,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.12, for a total value of $22,400.00.
  • On Wednesday, September 6th, Yoseph Bornstein sold 45,610 shares of Microbot Medical stock. The shares were sold at an average price of $1.01, for a total value of $46,066.10.

Shares of Microbot Medical Inc. (MBOT) opened at 1.36 on Friday. Microbot Medical Inc. has a one year low of $1.00 and a one year high of $15.66. The stock’s market cap is $59.90 million. The company has a 50 day moving average price of $1.18 and a 200-day moving average price of $2.48.

Microbot Medical (NASDAQ:MBOT) last announced its quarterly earnings results on Monday, August 14th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.48) by $0.44. Equities analysts predict that Microbot Medical Inc. will post ($25.02) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/2957139/yoseph-bornstein-sells-50000-shares-of-microbot-medical-inc-mbot-stock.html.

An institutional investor recently raised its position in Microbot Medical stock. Vanguard Group Inc. lifted its position in shares of Microbot Medical Inc. (NASDAQ:MBOT) by 252.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 159,992 shares of the biotechnology company’s stock after buying an additional 114,561 shares during the period. Vanguard Group Inc. owned approximately 0.43% of Microbot Medical worth $228,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 4.72% of the company’s stock.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.